These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36702320)

  • 41. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
    Abdin AA; Hasby EA
    Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
    Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
    [No Abstract]   [Full Text] [Related]  

  • 43. Gene Therapy with Single-Subunit Yeast NADH-Ubiquinone Oxidoreductase (NDI1) Improves the Visual Function in Experimental Autoimmune Encephalomyelitis (EAE) Mice Model of Multiple Sclerosis (MS).
    Talla V; Koilkonda R; Guy J
    Mol Neurobiol; 2020 Apr; 57(4):1952-1965. PubMed ID: 31900864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
    Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
    McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
    J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG; Hahn A
    J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.
    O'Malley HA; Shreiner AB; Chen GH; Huffnagle GB; Isom LL
    Mol Cell Neurosci; 2009 Feb; 40(2):143-55. PubMed ID: 19013247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS
    Curr Neurovasc Res; 2005 Oct; 2(4):349-62. PubMed ID: 16181126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Hu CL; Nydes M; Shanley KL; Morales Pantoja IE; Howard TA; Bizzozero OA
    J Neurochem; 2019 Feb; 148(3):426-439. PubMed ID: 30289974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of pathological stages in a mouse model of progressive multiple sclerosis.
    Hamano S; Yoshimizu T; Mori M; Iida A; Yamashita T
    Neurosci Res; 2024 Jul; 204():46-57. PubMed ID: 38307349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
    Mills Ko E; Ma JH; Guo F; Miers L; Lee E; Bannerman P; Burns T; Ko D; Sohn J; Soulika AM; Pleasure D
    J Neuroinflammation; 2014 Jun; 11():105. PubMed ID: 24924222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple sclerosis animal models: a clinical and histopathological perspective.
    Kipp M; Nyamoya S; Hochstrasser T; Amor S
    Brain Pathol; 2017 Mar; 27(2):123-137. PubMed ID: 27792289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
    Pöllinger B; Krishnamoorthy G; Berer K; Lassmann H; Bösl MR; Dunn R; Domingues HS; Holz A; Kurschus FC; Wekerle H
    J Exp Med; 2009 Jun; 206(6):1303-16. PubMed ID: 19487416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis.
    Tsunoda I; Libbey JE; Kuang LQ; Terry EJ; Fujinami RS
    Am J Pathol; 2005 Dec; 167(6):1631-46. PubMed ID: 16314476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.
    Cahill LS; Zhang MA; Ramaglia V; Whetstone H; Sabbagh MP; Yi TJ; Woo L; Przybycien TS; Moshkova M; Zhao FL; Rojas OL; Gomes J; Kuerten S; Gommerman JL; Sled JG; Dunn SE
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22710-22720. PubMed ID: 31641069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.